跳至主要内容
临床试验/CTRI/2025/10/096242
CTRI/2025/10/096242尚未招募不适用

Effect of Topical Losartan in Patients with Corneal Opacity: A Pilot Study.

DR RP CENTRE FOR OPHTHALMIC SCIENCES1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年11月3日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Effect of intervention on corneal opacity and scarring in terms of

研究概览

简要总结

This is a Pilot study to see the effect of Topical Losartan 0.08% eye drops in patients with corneal opacities compared to placebo.

Both patients and investigator will be blinded and patients will be randomly receiving either Topical Losartan 0.08% or the placebo (E/D CMC 0.5%) via pharmacy controlled randomization.

Patients will be asked to administer the eye drops 6 times a day and will be followed up at 2 weeks, 4 weeks, 12 weeks, 16 weeks when the effect of intervention will be compared based on area of opacity as seen on slit lamp biomicroscopy, depth of scarring as seen on AS-OCT, scheimpflug-based Corneal Densitometry values, improvement in visual acuity.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Consenting adults (age above 18 years) with corneal opacity due to Keratitis, Ocular Trauma, Trachoma.

排除标准

  • 1.Patients having active ulcer.
  • 2.Patients having active inflammation.
  • 3.Patients having active infection.
  • 5.Patients on systemic medication.

结局指标

主要结局

Effect of intervention on corneal opacity and scarring in terms of

时间窗: Baseline, 2 weeks, 4 weeks, 12 weeks and 16 weeks.

1.Area of opacity as seen on slit lamp biomicroscopy.

时间窗: Baseline, 2 weeks, 4 weeks, 12 weeks and 16 weeks.

2.Depth of scarring as seen on AS-OCT.

时间窗: Baseline, 2 weeks, 4 weeks, 12 weeks and 16 weeks.

3.Scheimpflug-based Corneal Densitometry values.

时间窗: Baseline, 2 weeks, 4 weeks, 12 weeks and 16 weeks.

4.Improvement in visual acuity.

时间窗: Baseline, 2 weeks, 4 weeks, 12 weeks and 16 weeks.

次要结局

未报告次要终点

研究者

发起方
DR RP CENTRE FOR OPHTHALMIC SCIENCES
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Lokesh Paras Mandlecha

DR RP CENTER OF OPHTHALMIC SCIENCE AIIMS

研究点 (1)

Loading locations...

相似试验

To Study the Effect of Topical Losartan Eye-drops in... | 临床试验